A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and parity in care for underserved patient populations. The initiative seeks to extend the reach of clinical studies to underserved populations in the nation’s urban and rural communities, and promote treatment development for all patient groups, the Bristol Myers Squibb Foundation and National Medical Fellowships announced in a press release. Funding will…
You must be logged in to read/download the full post.
The post New $100M Program Aims to Improve Diversity in Clinical Trials appeared first on BioNewsFeeds.